Library / Laws / 115th Congress / House Bills / H.R. 5247
H.R. 5247
To authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2018-03-13 | 12.6K | ⠃⠗⠋ |
| Engrossed in House | — | 12.0K | ⠃⠗⠋ |
| Placed on Calendar (Senate) | 2018-04-09 | 12.2K | ⠃⠗⠋ |